dc.contributor.author |
McLellan, JS |
|
dc.contributor.author |
Pancera, M |
|
dc.contributor.author |
Carrico, C |
|
dc.contributor.author |
Gorman, J |
|
dc.contributor.author |
Julien, JP |
|
dc.contributor.author |
Khayat, R |
|
dc.contributor.author |
Louder, R |
|
dc.contributor.author |
Pejchal, R |
|
dc.contributor.author |
Sastry, M |
|
dc.contributor.author |
Dai, K |
|
dc.contributor.author |
O'Dell, S |
|
dc.contributor.author |
Patel, N |
|
dc.contributor.author |
Shahzad ul Hussan, S |
|
dc.contributor.author |
Yang, Y |
|
dc.contributor.author |
Zhang, B |
|
dc.contributor.author |
Zhou, T |
|
dc.contributor.author |
Zhu, J |
|
dc.contributor.author |
Boyington, JC |
|
dc.contributor.author |
Chuang, GY |
|
dc.contributor.author |
Diwanji, D |
|
dc.contributor.author |
Georgiev, I |
|
dc.contributor.author |
Kwon, YD |
|
dc.contributor.author |
Lee, D |
|
dc.contributor.author |
Louder, MK |
|
dc.contributor.author |
Moquin, S |
|
dc.contributor.author |
Schmidt, SD |
|
dc.contributor.author |
Yang, ZY |
|
dc.contributor.author |
Bonsignori, M |
|
dc.contributor.author |
Crump, JA |
|
dc.contributor.author |
Kapiga, SH |
|
dc.contributor.author |
Sam, NE |
|
dc.contributor.author |
Haynes, BF |
|
dc.contributor.author |
Burton, DR |
|
dc.contributor.author |
Koff, WC |
|
dc.contributor.author |
Walker, LM |
|
dc.contributor.author |
Phogat, S |
|
dc.contributor.author |
Wyatt, R |
|
dc.contributor.author |
Orwenyo, J |
|
dc.contributor.author |
Wang, LX |
|
dc.contributor.author |
Arthos, J |
|
dc.contributor.author |
Bewley, CA |
|
dc.contributor.author |
Mascola, JR |
|
dc.contributor.author |
Nabel, GJ |
|
dc.contributor.author |
Schief, WR |
|
dc.contributor.author |
Ward, AB |
|
dc.contributor.author |
Wilson, IA |
|
dc.contributor.author |
Kwong, PD |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2017-03-02T19:25:40Z |
|
dc.date.available |
2017-03-02T19:25:40Z |
|
dc.date.issued |
2011-11-23 |
|
dc.identifier |
https://www.ncbi.nlm.nih.gov/pubmed/22113616 |
|
dc.identifier |
nature10696 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/13795 |
|
dc.description.abstract |
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope
glycoprotein are critical for viral evasion of antibody neutralization, and are themselves
protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies
such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we
report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded β-sheet
domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting
loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions:
the latter account for over half the interactive surface but are of sufficiently weak
affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04
and PGT145 indicate that they share a common mode of glycan penetration by extended
anionic loops. In addition to structurally defining V1/V2, the results thus identify
a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves
a site of vulnerability comprising just two glycans and a strand.
|
|
dc.language |
eng |
|
dc.publisher |
Springer Science and Business Media LLC |
|
dc.relation.ispartof |
Nature |
|
dc.relation.isversionof |
10.1038/nature10696 |
|
dc.subject |
AIDS Vaccines |
|
dc.subject |
Amino Acid Motifs |
|
dc.subject |
Amino Acid Sequence |
|
dc.subject |
Antibodies, Neutralizing |
|
dc.subject |
Antibody Affinity |
|
dc.subject |
Antibody Specificity |
|
dc.subject |
Antigen-Antibody Complex |
|
dc.subject |
Binding Sites, Antibody |
|
dc.subject |
Conserved Sequence |
|
dc.subject |
Crystallography, X-Ray |
|
dc.subject |
Epitopes |
|
dc.subject |
Glycopeptides |
|
dc.subject |
Glycosylation |
|
dc.subject |
HIV Antibodies |
|
dc.subject |
HIV Envelope Protein gp120 |
|
dc.subject |
HIV-1 |
|
dc.subject |
Hydrogen Bonding |
|
dc.subject |
Immune Evasion |
|
dc.subject |
Models, Molecular |
|
dc.subject |
Molecular Sequence Data |
|
dc.subject |
Polysaccharides |
|
dc.subject |
Protein Structure, Quaternary |
|
dc.subject |
Protein Structure, Tertiary |
|
dc.title |
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. |
|
dc.type |
Journal article |
|
duke.contributor.id |
Bonsignori, M|0383217 |
|
duke.contributor.id |
Crump, JA|0231646 |
|
duke.contributor.id |
Haynes, BF|0114780 |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/22113616 |
|
pubs.begin-page |
336 |
|
pubs.end-page |
343 |
|
pubs.issue |
7377 |
|
pubs.organisational-group |
Basic Science Departments |
|
pubs.organisational-group |
Clinical Science Departments |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Duke Cancer Institute |
|
pubs.organisational-group |
Duke Human Vaccine Institute |
|
pubs.organisational-group |
Global Health Institute |
|
pubs.organisational-group |
Immunology |
|
pubs.organisational-group |
Institutes and Centers |
|
pubs.organisational-group |
Institutes and Provost's Academic Units |
|
pubs.organisational-group |
Medicine |
|
pubs.organisational-group |
Medicine, Duke Human Vaccine Institute |
|
pubs.organisational-group |
Medicine, Infectious Diseases |
|
pubs.organisational-group |
Pathology |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
University Institutes and Centers |
|
pubs.publication-status |
Published online |
|
pubs.volume |
480 |
|
dc.identifier.eissn |
1476-4687 |
|
duke.contributor.orcid |
Bonsignori, M|0000-0003-2973-2101 |
|